Blood Donation News and Research

RSS
Two fully automated molecular testing systems for blood and plasma donor screening launched by Roche

Two fully automated molecular testing systems for blood and plasma donor screening launched by Roche

Experts to debate healthy labor and delivery practices at Cedars-Sinai Birth Community Day

Experts to debate healthy labor and delivery practices at Cedars-Sinai Birth Community Day

National Gay Blood Drive to take place on July 11, 2014

National Gay Blood Drive to take place on July 11, 2014

Penn’s immunotherapy receives FDA's Breakthrough Therapy designation for ALL treatment

Penn’s immunotherapy receives FDA's Breakthrough Therapy designation for ALL treatment

Scientists design new system for molecular blood group typing

Scientists design new system for molecular blood group typing

NBTS Sri Lanka to use Transfusion Evidence Library to ensure quality, safety of blood supply

NBTS Sri Lanka to use Transfusion Evidence Library to ensure quality, safety of blood supply

Celgene subsidiary presents REVLIMID study results on lymphoma at ASH annual meeting

Celgene subsidiary presents REVLIMID study results on lymphoma at ASH annual meeting

Growing cord blood stem cells in lab before transplant boosts survival, study finds

Growing cord blood stem cells in lab before transplant boosts survival, study finds

New method for improving cord blood transplant success

New method for improving cord blood transplant success

Phobias, anxiety are typical reasons why many decline to donate blood

Phobias, anxiety are typical reasons why many decline to donate blood

Implementation of better blood-management plan changes culture at UAB

Implementation of better blood-management plan changes culture at UAB

IGTP, UAB discover first genetic biomarker to detect Lewy body dementia

IGTP, UAB discover first genetic biomarker to detect Lewy body dementia

Celgene to discontinue treatment with REVLIMID in phase III ORIGIN trial

Celgene to discontinue treatment with REVLIMID in phase III ORIGIN trial

Gay men plan blood donation protest

Gay men plan blood donation protest

Phase III study: REVLIMID meets primary endpoint in patients newly diagnosed with multiple myeloma

Phase III study: REVLIMID meets primary endpoint in patients newly diagnosed with multiple myeloma

European Commission amends marketing authorisation for Celgene's REVLIMID

European Commission amends marketing authorisation for Celgene's REVLIMID

Four studies show that OrSense's non-invasive NBM-200 Hb monitor is safe and accurate

Four studies show that OrSense's non-invasive NBM-200 Hb monitor is safe and accurate

Prior administration of erythropoietin reduces need for blood transfusions

Prior administration of erythropoietin reduces need for blood transfusions

SCCA pioneers new transplant procedures to reduce need for matching bone marrow donors

SCCA pioneers new transplant procedures to reduce need for matching bone marrow donors

New two-step immunotherapy approach offers new hope for ovarian cancer patients

New two-step immunotherapy approach offers new hope for ovarian cancer patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.